Whole Genome Sequencing in Breast Cancer
Recruiting
Observational Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,200 (estimated)
- Sponsor
- Inocras Korea Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to conduct whole genome sequencing in breast cancer patients to elucidate individual genetic characteristics and their correlation with breast cancer subtypes. The primary objective is to establish new treatment guidelines aligned with the paradigm shift in precision medicine. The study will include both prospective and retrospective cohorts totaling 1200 participants. Prospective …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
\[Prospective study\]
Inclusion Criteria:
* Patients who have consented to both the patient consent form and the consent for the use of human-derived materials.
* Patients who are aged 19 years or older at the time of signing the consent form.
* Patients capable of providing written consent to par…
Contacts